In the first blog we introduced HIV/AIDS, in the second we discussed the initial management, and in this third and final blog of the series we will examine the current and future treatments for HIV/AIDS. Evolution of treatments for HIV Treatments for HIV have evolved...
The beginning of treatments for HIV/AIDS In 1964, Jerome Horwitz developed azidothymidine (AZT) as a potential cancer therapy. It was shown to be ineffective and was subsequently shelved. However, in the 1980s it was included by the National Cancer Institute (NCI) in...
By Pasha Yuen International HPV Awareness Day, observed annually on 4th March, serves as a crucial initiative to enhance public understanding of human papillomavirus (HPV). This global campaign aims to educate individuals about what HPV is, the risks associated with...
Immunisation Masterclass: Part 2 By Pasha Yuen Please click here to read the 1st Immunisation Masterclass ‘Why Vaccinate?’ Oral VaccinesWhen talking about vaccines, the first thing that comes to your mind may be getting an injection. However, some vaccines...
Introduction to HIV and patient outcomes - Masterclass 1 By Joshua Bryning What is HIV/AIDS?Human Immunodeficiency Virus (HIV) is a retrovirus that attacks a person’s immune system, in turn affecting their ability to fight off infections and diseases. More...
Pharmora RMP Masterclass (3) Updates to EMA guidance on RMMs By Srirekha Boddu Click here for Pharmora RMP Masterclass (1) and here for Pharmora RMP Masterclass (2) On 11th September this year Pharmora attended the EMA webinar to launch the updates to GVP Module XVI...
